These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparable efficacy of a topical 0.0584% hydrocortisone aceponate spray and oral ciclosporin in treating canine atopic dermatitis. Nuttall TJ; McEwan NA; Bensignor E; Cornegliani L; Löwenstein C; Rème CA Vet Dermatol; 2012 Feb; 23(1):4-10, e1-2. PubMed ID: 21718368 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of a 0.0584% hydrocortisone aceponate spray in the management of canine atopic dermatitis: a randomised, double blind, placebo-controlled trial. Nuttall T; Mueller R; Bensignor E; Verde M; Noli C; Schmidt V; Rème C Vet Dermatol; 2009 Jun; 20(3):191-8. PubMed ID: 19374721 [TBL] [Abstract][Full Text] [Related]
4. Management of canine atopic dermatitis using the plant extract PYM00217: a randomized, double-blind, placebo-controlled clinical study. Ferguson EA; Littlewood JD; Carlotti DN; Grover R; Nuttall T Vet Dermatol; 2006 Aug; 17(4):236-43. PubMed ID: 16827666 [TBL] [Abstract][Full Text] [Related]
5. Investigation on the clinical efficacy and safety of 0.1% tacrolimus ointment (Protopic) in canine atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over study. Marsella R; Nicklin CF; Saglio S; Lopez J Vet Dermatol; 2004 Oct; 15(5):294-303. PubMed ID: 15500481 [TBL] [Abstract][Full Text] [Related]
6. The glucocorticoid sparing efficacy of Phytopica in the management of canine atopic dermatitis. Schmidt V; McEwan N; Volk A; Helps J; Morrell K; Nuttall T Vet Dermatol; 2010 Feb; 21(1):96-105. PubMed ID: 20187915 [TBL] [Abstract][Full Text] [Related]
7. Tepoxalin reduces pruritus and modified CADESI-01 scores in dogs with atopic dermatitis: a prospective, randomized, double-blinded, placebo-controlled, cross-over study. Horvath-Ungerboeck C; Thoday KL; Shaw DJ; van den Broek AH Vet Dermatol; 2009 Aug; 20(4):233-42. PubMed ID: 19552701 [TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled study to evaluate the effect of EFF1001, an Actinidia arguta (hardy kiwi) preparation, on CADESI score and pruritus in dogs with mild to moderate atopic dermatitis. Marsella R; Messinger L; Zabel S; Rosychuck R; Griffin C; Cronin PO; Belofsky G; Lindemann J; Stull D Vet Dermatol; 2010 Feb; 21(1):50-7. PubMed ID: 19843302 [TBL] [Abstract][Full Text] [Related]
9. Masitinib for the treatment of canine atopic dermatitis: a pilot study. Daigle J; Moussy A; Mansfield CD; Hermine O Vet Res Commun; 2010 Jan; 34(1):51-63. PubMed ID: 20033487 [TBL] [Abstract][Full Text] [Related]
10. The use of recombinant omega interferon therapy in canine atopic dermatitis: a double-blind controlled study. Carlotti DN; Boulet M; Ducret J; Machicote G; Jasmin P; Rème CA; Albouy M Vet Dermatol; 2009 Oct; 20(5-6):405-11. PubMed ID: 20178477 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of a human generic formulation of ciclosporin in the treatment of canine atopic dermatitis with in vitro assessment of the functional capacity of phagocytic cells. Kovalik M; Taszkun I; Pomorski Z; Kozak M; Pomorska D; Szczepanik M; Wilkolek P; Palenik L; Shaw DJ; van den Broek AH; Thoday KL Vet Rec; 2011 May; 168(20):537. PubMed ID: 21558130 [TBL] [Abstract][Full Text] [Related]
12. Long-term use of cyclosporine in the treatment of canine atopic dermatitis. Radowicz SN; Power HT Vet Dermatol; 2005 Apr; 16(2):81-6. PubMed ID: 15842537 [TBL] [Abstract][Full Text] [Related]
13. A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs. Little PR; King VL; Davis KR; Cosgrove SB; Stegemann MR Vet Dermatol; 2015 Feb; 26(1):23-30, e7-8. PubMed ID: 25496303 [TBL] [Abstract][Full Text] [Related]
14. Treatment of localized lesions of canine atopic dermatitis with tacrolimus ointment: a blinded randomized controlled trial. Bensignor E; Olivry T Vet Dermatol; 2005 Feb; 16(1):52-60. PubMed ID: 15725106 [TBL] [Abstract][Full Text] [Related]
15. The effect of a spot-on formulation containing polyunsaturated fatty acids and essential oils on dogs with atopic dermatitis. Blaskovic M; Rosenkrantz W; Neuber A; Sauter-Louis C; Mueller RS Vet J; 2014 Jan; 199(1):39-43. PubMed ID: 24355814 [TBL] [Abstract][Full Text] [Related]
16. The efficacy of a commercial shampoo and whirlpooling in the treatment of canine pruritus - a double-blinded, randomized, placebo-controlled study. Löflath A; von Voigts-Rhetz A; Jaeger K; Schmid M; Kuechenhoff H; Mueller RS Vet Dermatol; 2007 Dec; 18(6):427-31. PubMed ID: 17991160 [TBL] [Abstract][Full Text] [Related]
17. Intradermal injection of heat-killed Mycobacterium vaccae in dogs with atopic dermatitis: a multicentre pilot study. Ricklin Gutzwiller ME; Reist M; Peel JE; Seewald W; Brunet LR; Roosje PJ Vet Dermatol; 2007 Apr; 18(2):87-93. PubMed ID: 17355422 [TBL] [Abstract][Full Text] [Related]
18. Masitinib is safe and effective for the treatment of canine mast cell tumors. Hahn KA; Ogilvie G; Rusk T; Devauchelle P; Leblanc A; Legendre A; Powers B; Leventhal PS; Kinet JP; Palmerini F; Dubreuil P; Moussy A; Hermine O J Vet Intern Med; 2008; 22(6):1301-9. PubMed ID: 18823406 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of low dose immunotherapy in the treatment of canine atopic dermatitis: a prospective, double-blinded, clinical study. Colombo S; Hill PB; Shaw DJ; Thoday KL Vet Dermatol; 2005 Jun; 16(3):162-70. PubMed ID: 15960629 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]